Valuation: Burning Rock Biotech Limited

Market Cap 713M 105M 91.89M 84.79M 78.16M 147M 10.13B 151M 1.01B 399M 4.96B 395M 386M 17.07B P/E 2024
-1.46x
P/E 2025 -27.1x
Enterprise Value 275M 40.58M 35.46M 32.72M 30.16M 56.85M 3.91B 58.11M 391M 154M 1.91B 152M 149M 6.59B EV / Sales 2024
0.06x
EV / Sales 2025 2x
Free-Float
61.34%
Yield 2024 *
-
Yield 2025 -
1 day+3.80%
1 week-11.77%
Current month+19.12%
1 month+41.62%
3 months-51.77%
6 months-68.85%
Current year-50.52%
1 week 8.68
Extreme 8.68
11.01
1 month 7.23
Extreme 7.23
12.89
Current year 6.79
Extreme 6.79
41.72
1 year 4.75
Extreme 4.75
41.72
3 years 2.18
Extreme 2.18
41.72
5 years 2.18
Extreme 2.18
281.8
10 years 2.18
Extreme 2.18
397.5
Manager TitleAgeSince
Corporate Officer/Principal - 01/01/2014
Chief Executive Officer 48 01/01/2014
Director of Finance/CFO - 27/09/2024
Director TitleAgeSince
Chairman 48 -
Director/Board Member 55 01/06/2014
Director/Board Member 63 01/08/2016
Date Insider Type Main position Quantity % Market Cap.
26/6/26 Buy

Chief Executive Officer

24,900 0.0283%
31/3/26 Buy

Chief Executive Officer

314,870 0.3584%
18/3/26
Northern Light Venture Capital Development Ltd.
OtherCompany 11,880,245 13.5213%
Change 5-day change 1-year change 3-year change Capi.($)
+3.80%-11.77%+116.27%-54.89% 105M
-0.50%+4.05%+26.36%+9.46% 10B
-7.34%+7.59% - - 1.37B
+1.32%+3.62%+14.23%+3.78% 1.33B
+0.93%+2.73%+2.16%-9.63% 1.09B
-9.96%-3.64%+44.60%+24.52% 605M
-3.44%+2.47%-20.89%-53.07% 600M
-1.81%+1.29%-12.15%-16.91% 411M
0.00%+0.58%+106.90%+160.65% 416M
-8.20%+1.46%-56.57%-82.00% 266M
Average -2.52%+0.52%+24.55%-2.01% 1.62B
Weighted average by Cap. -1.42%+3.24%+22.67%+7.05%

Financials

2024 2025
Net sales 516M 76.1M 66.5M 61.37M 56.57M 107M 7.33B 109M 734M 289M 3.59B 286M 280M 12.36B 540M 79.6M 69.57M 64.19M 59.17M 112M 7.67B 114M 767M 302M 3.75B 299M 292M 12.92B
Net income -347M -51.14M -44.69M -41.24M -38.01M -71.64M -4.92B -73.24M -493M -194M -2.41B -192M -188M -8.3B -55.35M -8.17M -7.14M -6.58M -6.07M -11.44M -786M -11.69M -78.7M -30.96M -385M -30.66M -29.99M -1.33B
Net Debt -474M -69.88M -61.07M -56.35M -51.94M -97.9M -6.73B -100M -674M -265M -3.3B -262M -257M -11.35B -438M -64.57M -56.43M -52.07M -48M -90.46M -6.22B -92.47M -622M -245M -3.05B -242M -237M -10.48B
Logo Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Employees
667
Date Price Change Volume
17/07/26 US$9.970 +3.80% 4,132
16/07/26 US$9.605 +3.28% 15,497
15/07/26 US$9.300 -6.44% 15,410
14/07/26 US$9.940 -6.75% 7,356
13/07/26 US$10.66 -5.66% 23,562